ReviewDiscover oncology2026
The emerging role of exosomal circRNAs in modulating apoptotic pathways and overcoming cancer therapy resistance.
Review in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Exosomal circular RNAs (circRNAs) have emerged as key regulators of tumor apoptosis, with significant implications for cancer development and treatment response. These persistent, covalently closed-loop RNAs are preferentially packed into exosomes, which are nanoscale extracellular vesicles that allow cells to communicate within the tumor microenvironment. This study investigates the molecular mechanisms underlying exosomal circRNA synthesis, selective cargo sorting, and their modulatory effects on apoptotic signaling pathways in various malignancies, including hepatocellular carcinoma, lung, gastric, pancreatic, and colorectal cancers. Exosomal circRNAs regulate apoptosis primarily through microRNA sponging, interaction with RNA-binding proteins, and the encoding of functional peptides, which influence tumor cell survival, treatment resistance, and metastatic potential. We highlight recent advances in the translational potential of exosomal circRNAs as diagnostic biomarkers and therapeutic targets for overcoming apoptosis evasion in malignancies. Targeting exosomal circRNA-mediated apoptotic networks is a promising approach to precision oncology and better clinical outcomes. This review highlights the critical need for more mechanistic and clinical investigations to utilize exosome biology in cancer therapy innovation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.